Science and Research

Correction to: Key summary of German national treatment guidance for hospitalized COVID19 patients : Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021)

No abstract available.

Author

J. J. Malin, C. D. Spinner, U. Janssens, T. Welte, S. Weber-Carstens, G. Schalte, P. Gastmeier, F. Langer, M. Wepler, M. Westhoff, M. Pfeifer, K. F. Rabe, F. Hoffmann, B. W. Bottiger, J. Weinmann-Menke, A. Kersten, P. Berlit, M. Krawczyk, W. Nehls, F. Fichtner, S. Laudi, M. Stegemann, N. Skoetz, M. Nothacker, G. Marx, C. Karagiannidis and S. Kluge

DZL Members with Authorship (* = Corresponding Author)

T. Welte, K. F. Rabe
Guideline details
DOI: 10.1007/s15010-021-01665-y
Work Type: Other
Partner / Member: Ghd, KUM, MHH, UMR
DZL Site: ARCN, BREATH, CPC-M, UGMLC
Disease Area: PALI
Reach: national
Year: 2021
Link to PubMedLink to Original Publication


chevron-down